{"DataElement":{"publicId":"8081470","version":"1","preferredName":"Biospecimen Events Domain Vendor Sponsor Defined Name","preferredDefinition":"Terminology assigned by the sponsor to the codelist associated with the vendor that performs a biospecimen assessment or examination.","longName":"BENAM_SPD","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"8075211","version":"1","preferredName":"Biospecimen Events Domain Vendor Name","preferredDefinition":"An events domain that documents biospecimen collection and storage information._The literal identifier of the vendor that performs an assessment or examination.","longName":"6983057v1.0:7044579v1.0","context":"Theradex","contextVersion":"1","ObjectClass":{"publicId":"6983057","version":"1","preferredName":"Biospecimen Events Domain","preferredDefinition":"An events domain that documents biospecimen collection and storage information.","longName":"C111138","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biospecimen Events Domain","conceptCode":"C111138","definition":"An events domain that documents biospecimen collection and storage information.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"94E41BF3-F82C-2CB7-E053-F662850A84C2","latestVersionIndicator":"Yes","beginDate":"2019-10-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-10-14","modifiedBy":"ONEDATA","dateModified":"2019-10-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7044579","version":"1","preferredName":"Vendor Name","preferredDefinition":"The literal identifier of the vendor that performs an assessment or examination.","longName":"C117200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vendor Name","conceptCode":"C117200","definition":"The literal identifier of the vendor that performs an assessment or examination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"96B3551B-DFFA-3B2B-E053-F662850A0442","latestVersionIndicator":"Yes","beginDate":"2019-11-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-11-06","modifiedBy":"ONEDATA","dateModified":"2019-11-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008528","version":"1","preferredName":"Protocol Administration","preferredDefinition":"the management of a research protocol and its case report forms.","longName":"PROT_ADM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ECAD41-A932-34B1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9CCD54B-2D1A-723D-E053-4EBD850A8345","latestVersionIndicator":"Yes","beginDate":"2022-03-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-03-09","modifiedBy":"TAYLORT","dateModified":"2022-04-18","changeDescription":"Leidos Biospecimen Roadmap; TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"8078544","version":"1","preferredName":"Vendor Clinical Study Sponsor Defined Name","preferredDefinition":"The literal identifier of the vendor that performs an assessment or examination._An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]_Clearly characterized or delimited._The words or language units by which a thing is known.","longName":"VEN_NAM_SPD","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"NCLN PD Assay Lab at Molecular Path Network","valueDescription":"Molecular Pathology Laboratory Network National Clinical Laboratory Network Pharmacodynamics Assay Laboratory","ValueMeaning":{"publicId":"8083707","version":"1","preferredName":"Molecular Pathology Laboratory Network National Clinical Laboratory Network Pharmacodynamics Assay Laboratory","longName":"8083707","preferredDefinition":"A contract diagnostic laboratory providing molecular diagnostics, specialty anatomic pathology, flow cytometry, fluorescence in situ hybridization, and cytogenetic testing.: A laboratory network capable of providing centralized, well-characterized assays. It features a centralized specimen biorepository and the support of centralized data reporting and offers validated assays following harmonized standardized operating procedures (SOPs) while implementing uniform assay workflow, instrumentation, and data analysis across network labs.: A laboratory that specializes in developing biomarkers and monitoring the biological effects of drugs during drug development.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Molecular Pathology Laboratory Network","conceptCode":"C186299","definition":"A contract diagnostic laboratory providing molecular diagnostics, specialty anatomic pathology, flow cytometry, fluorescence in situ hybridization, and cytogenetic testing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"National Clinical Laboratory Network","conceptCode":"C186303","definition":"A laboratory network capable of providing centralized, well-characterized assays. It features a centralized specimen biorepository and the support of centralized data reporting and offers validated assays following harmonized standardized operating procedures (SOPs) while implementing uniform assay workflow, instrumentation, and data analysis across network labs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pharmacodynamics Assay Laboratory","conceptCode":"C186300","definition":"A laboratory that specializes in developing biomarkers and monitoring the biological effects of drugs during drug development.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DA317ED6-388B-0AB2-E053-4EBD850AA2A7","latestVersionIndicator":"Yes","beginDate":"2022-03-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-03-14","modifiedBy":"ONEDATA","dateModified":"2022-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DA317ED6-38A6-0AB2-E053-4EBD850AA2A7","beginDate":"2022-03-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-03-14","modifiedBy":"ONEDATA","dateModified":"2022-03-14","deletedIndicator":"No"},{"value":"PADIS Lab at Frederick","valueDescription":"Frederick Cancer Research and Development Center Pharmacodynamics Assay Development Laboratory","ValueMeaning":{"publicId":"8083709","version":"1","preferredName":"Frederick Cancer Research and Development Center Pharmacodynamics Assay Development Laboratory","longName":"8083709","preferredDefinition":"A government-owned, contractor operated cancer research facility located in Frederick, MD.  Operated under the direction of the Division of Cancer Biology.: A laboratory that specializes in developing biomarkers for use during drug development.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Frederick Cancer Research and Development Center","conceptCode":"C18801","definition":"A government-owned, contractor operated cancer research facility located in Frederick, MD.  Operated under the direction of the Division of Cancer Biology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pharmacodynamics Assay Development Laboratory","conceptCode":"C186301","definition":"A laboratory that specializes in developing biomarkers for use during drug development.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DA324EF2-6D44-5BE3-E053-4EBD850A9DB9","latestVersionIndicator":"Yes","beginDate":"2022-03-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-03-14","modifiedBy":"ONEDATA","dateModified":"2022-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DA324EF2-6D5F-5BE3-E053-4EBD850A9DB9","beginDate":"2022-03-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-03-14","modifiedBy":"ONEDATA","dateModified":"2022-03-14","deletedIndicator":"No"},{"value":"MDACC Tissue Qualification Laboratory (TQL)","valueDescription":"MD Anderson Tissue Qualification Laboratory","ValueMeaning":{"publicId":"8083711","version":"1","preferredName":"MD Anderson Tissue Qualification Laboratory","longName":"8083711","preferredDefinition":"A facility at the MD Anderson Cancer Center that stores clinical tissue specimens for archiving and retrieval.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MD Anderson Tissue Qualification Laboratory","conceptCode":"C186302","definition":"A facility at the MD Anderson Cancer Center that stores clinical tissue specimens for archiving and retrieval.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DA322363-C343-0822-E053-4EBD850AAAFC","latestVersionIndicator":"Yes","beginDate":"2022-03-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-03-14","modifiedBy":"ONEDATA","dateModified":"2022-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DA322363-C35E-0822-E053-4EBD850AAAFC","beginDate":"2022-03-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-03-14","modifiedBy":"ONEDATA","dateModified":"2022-03-14","deletedIndicator":"No"},{"value":"NCLN Genomics Laboratory at MDA","valueDescription":"University of Texas MD Anderson Cancer Center National Clinical Laboratory Network Genomics Laboratory","ValueMeaning":{"publicId":"8083710","version":"1","preferredName":"University of Texas MD Anderson Cancer Center National Clinical Laboratory Network Genomics Laboratory","longName":"8083710","preferredDefinition":"The mission areas of the University of Texas MD Anderson Cancer Center include patient care, research, education, and prevention, with an emphasis on cancer control and prevention trials. It strives to rapidly translate scientific knowledge into better cancer therapies and prevention strategies. It was named an NCI-designated comprehensive cancer center in 1971.: A laboratory network capable of providing centralized, well-characterized assays. It features a centralized specimen biorepository and the support of centralized data reporting and offers validated assays following harmonized standardized operating procedures (SOPs) while implementing uniform assay workflow, instrumentation, and data analysis across network labs.: A molecular biology laboratory that focuses on the development of genetics and genomics technologies, together with associated laboratory automation systems, data analysis, and information management tools.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"University of Texas MD Anderson Cancer Center","conceptCode":"C39557","definition":"The mission areas of the University of Texas MD Anderson Cancer Center include patient care, research, education, and prevention, with an emphasis on cancer control and prevention trials. It strives to rapidly translate scientific knowledge into better cancer therapies and prevention strategies. It was named an NCI-designated comprehensive cancer center in 1971.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"National Clinical Laboratory Network","conceptCode":"C186303","definition":"A laboratory network capable of providing centralized, well-characterized assays. It features a centralized specimen biorepository and the support of centralized data reporting and offers validated assays following harmonized standardized operating procedures (SOPs) while implementing uniform assay workflow, instrumentation, and data analysis across network labs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Genomics Laboratory","conceptCode":"C186297","definition":"A molecular biology laboratory that focuses on the development of genetics and genomics technologies, together with associated laboratory automation systems, data analysis, and information management tools.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DA323DB8-2421-2C40-E053-4EBD850A8C8A","latestVersionIndicator":"Yes","beginDate":"2022-03-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-03-14","modifiedBy":"ONEDATA","dateModified":"2022-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DA323DB8-243C-2C40-E053-4EBD850A8C8A","beginDate":"2022-03-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-03-14","modifiedBy":"ONEDATA","dateModified":"2022-03-14","deletedIndicator":"No"},{"value":"EET Biobank","valueDescription":"NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank","ValueMeaning":{"publicId":"8083704","version":"1","preferredName":"NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank","longName":"8083704","preferredDefinition":"A biorepository responsible for collecting, processing and storing a variety of human specimens from patients with cancer who are participating in NCI-funded Experimental Therapeutics Clinical Trials Network (ETCTN) and other NCI-supported early and experimental clinical trials.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank","conceptCode":"C186296","definition":"A biorepository responsible for collecting, processing and storing a variety of human specimens from patients with cancer who are participating in NCI-funded Experimental Therapeutics Clinical Trials Network (ETCTN) and other NCI-supported early and experimental clinical trials.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DA31659C-9BBC-7C1D-E053-4EBD850AE384","latestVersionIndicator":"Yes","beginDate":"2022-03-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-03-14","modifiedBy":"ONEDATA","dateModified":"2022-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DA31659C-9BD7-7C1D-E053-4EBD850AE384","beginDate":"2022-03-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-03-14","modifiedBy":"ONEDATA","dateModified":"2022-03-14","deletedIndicator":"No"},{"value":"NCLN PD Assay Laboratory at MD Anderson","valueDescription":"University of Texas MD Anderson Cancer Center National Clinical Laboratory Network Pharmacodynamics Assay Laboratory","ValueMeaning":{"publicId":"8083706","version":"1","preferredName":"University of Texas MD Anderson Cancer Center National Clinical Laboratory Network Pharmacodynamics Assay Laboratory","longName":"8083706","preferredDefinition":"The mission areas of the University of Texas MD Anderson Cancer Center include patient care, research, education, and prevention, with an emphasis on cancer control and prevention trials. It strives to rapidly translate scientific knowledge into better cancer therapies and prevention strategies. It was named an NCI-designated comprehensive cancer center in 1971.: A laboratory network capable of providing centralized, well-characterized assays. It features a centralized specimen biorepository and the support of centralized data reporting and offers validated assays following harmonized standardized operating procedures (SOPs) while implementing uniform assay workflow, instrumentation, and data analysis across network labs.: A laboratory that specializes in developing biomarkers and monitoring the biological effects of drugs during drug development.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"University of Texas MD Anderson Cancer Center","conceptCode":"C39557","definition":"The mission areas of the University of Texas MD Anderson Cancer Center include patient care, research, education, and prevention, with an emphasis on cancer control and prevention trials. It strives to rapidly translate scientific knowledge into better cancer therapies and prevention strategies. It was named an NCI-designated comprehensive cancer center in 1971.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"National Clinical Laboratory Network","conceptCode":"C186303","definition":"A laboratory network capable of providing centralized, well-characterized assays. It features a centralized specimen biorepository and the support of centralized data reporting and offers validated assays following harmonized standardized operating procedures (SOPs) while implementing uniform assay workflow, instrumentation, and data analysis across network labs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pharmacodynamics Assay Laboratory","conceptCode":"C186300","definition":"A laboratory that specializes in developing biomarkers and monitoring the biological effects of drugs during drug development.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DA31659C-9BE6-7C1D-E053-4EBD850AE384","latestVersionIndicator":"Yes","beginDate":"2022-03-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-03-14","modifiedBy":"TAYLORT","dateModified":"2022-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DA31659C-9C01-7C1D-E053-4EBD850AE384","beginDate":"2022-03-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-03-14","modifiedBy":"ONEDATA","dateModified":"2022-03-14","deletedIndicator":"No"},{"value":"Frederick MoCha Lab","valueDescription":"Frederick National Laboratory for Cancer Research Molecular Characterization Laboratory","ValueMeaning":{"publicId":"8083705","version":"1","preferredName":"Frederick National Laboratory for Cancer Research Molecular Characterization Laboratory","longName":"8083705","preferredDefinition":"The Molecular Characterization Laboratory at the Frederick National Laboratory for Cancer Research (FNLCR) is a clinical and research laboratory that performs genomic sequencing in support of clinical and pre-clinical studies sponsored by the National Cancer Institute's Division of Cancer Treatment and Diagnosis (DCTD).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Frederick National Laboratory for Cancer Research Molecular Characterization Laboratory","conceptCode":"C186298","definition":"The Molecular Characterization Laboratory at the Frederick National Laboratory for Cancer Research (FNLCR) is a clinical and research laboratory that performs genomic sequencing in support of clinical and pre-clinical studies sponsored by the National Cancer Institute's Division of Cancer Treatment and Diagnosis (DCTD).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DA31699F-D535-01D5-E053-4EBD850AF073","latestVersionIndicator":"Yes","beginDate":"2022-03-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-03-14","modifiedBy":"ONEDATA","dateModified":"2022-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DA31699F-D550-01D5-E053-4EBD850AF073","beginDate":"2022-03-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-03-14","modifiedBy":"ONEDATA","dateModified":"2022-03-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008528","version":"1","preferredName":"Protocol Administration","preferredDefinition":"the management of a research protocol and its case report forms.","longName":"PROT_ADM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ECAD41-A932-34B1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"8078543","version":"1","preferredName":"Vendor Name Clinical Study Sponsor Defined Name","preferredDefinition":"The literal identifier of the vendor that performs an assessment or examination.:An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]:Clearly characterized or delimited.:The words or language units by which a thing is known.","longName":"C117200:C70793:C165683:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vendor Name","conceptCode":"C117200","definition":"The literal identifier of the vendor that performs an assessment or examination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Clinical Study Sponsor","conceptCode":"C70793","definition":"An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Defined","conceptCode":"C165683","definition":"Clearly characterized or delimited.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9DE0C7D-163E-6BB4-E053-4EBD850A7108","latestVersionIndicator":"Yes","beginDate":"2022-03-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-03-10","modifiedBy":"ONEDATA","dateModified":"2022-03-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9DE0C7D-164F-6BB4-E053-4EBD850A7108","latestVersionIndicator":"Yes","beginDate":"2022-03-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-03-10","modifiedBy":"TAYLORT","dateModified":"2022-04-18","changeDescription":"Leidos Biospecimen Roadmap; TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"7668442","version":"1","longName":"CDISC Content","context":"Theradex","ClassificationSchemeItems":[{"publicId":"7668399","version":"1","longName":"CDASH Compliant","context":"Theradex"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Vendor Name","type":"Preferred Question Text","description":"Vendor Name","url":null,"context":"Theradex"},{"name":"Theradex - 1","type":"Alternate Question Text","description":"Destination","url":null,"context":"Theradex"},{"name":"Theradex - 2","type":"Alternate Question Text","description":"Source","url":null,"context":"Theradex"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9F1C569-D822-6B39-E053-4EBD850A88B6","latestVersionIndicator":"Yes","beginDate":"2022-03-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-03-11","modifiedBy":"TAYLORT","dateModified":"2022-04-18","changeDescription":"Leidos Biospecimen Roadmap; TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}